期刊文献+

骨形态发生蛋白9对人乳腺癌MDA-MB-231细胞增殖和凋亡的影响 被引量:5

Effects of bone morphogenetic protein 9 on the proliferation and apoptosis of breast cancer MDA-MB-231 cells
原文传递
导出
摘要 目的:探讨骨形态发生蛋白9(bone morphogenetic protein9,BMP9)在体内、外对人乳腺癌MDA-MB-231细胞增殖和凋亡的影响。方法:将pAdtrack-CMV/BMP9和pAdtrack-CMV/GFP腺病毒感染MDA-MB-231细胞,RT-PCR法检测MDA-MB-231/GFP和MDA-MB-231/BMP9细胞中BMP9mRNA的表达,MTT法、平板集落形成实验和FCM法检测细胞增殖和凋亡的情况。建立裸鼠MDA-MB-231、MDA-MB-231/GFP和MDA-MB-231/BMP9移植瘤模型,测量移植瘤体积,TUNEL法检测肿瘤细胞的凋亡情况。结果:MDA-MB-231和MDA-MB-231/GFP细胞中无BMP9mRNA的表达,MDA-MB-231/BMP9细胞中有明显BMP9mRNA表达;MDA-MB-231/BMP9细胞增殖抑制率高于MDA-MB-231/GFP细胞(P<0.05),而细胞集落形成率明显低于MDA-MB-231/GFP和MDA-MB-231组(P<0.05),细胞凋亡率则明显高于MDA-MB-231/GFP和MDA-MB-231组(P<0.05)。MDA-MB-231/BMP9组的裸鼠移植瘤体积明显小于MDA-MB-231/GFP和MDA-MB-231组(P<0.001),而移植瘤细胞中的凋亡指数则明显高于MDA-MB-231/GFP和MDA-MB-231组(P<0.001)。结论:BMP9可在体内、外抑制人乳腺癌MDA-MB-231细胞增殖并促进其凋亡。 Objective: To investigate the effects of bone morphogenetic protein 9 (BMP9) on the proliferation and apoptosis of breast cancer MDA-MB-231 cells in vitro and in vivo. Methods: MDA-MB-231 cells were infected with pAdtrack-CMV/BMP9 or pAdtrack-CMV/GFP adenovirus. The expression levels of BMP9 mRNA in MDA-MB-231/GFP and MDA-MB-231/BMP9 cells were detected by RT-PCR. The proliferation inhibitory rate and the apoptosis rate of breast cancer cells were determined by MTT assay, colony-forming assay and flow cytometry method. Then the breast cancer MDA-MB-231, MDA-MB-231/GFP or MDA-MB-231/BMP9 xenografts in nude mice were established. The volume of xenograft tumor was measured, and the apoptosis rate was detected by TUNEL assay. Results: There was no expression of BMP9 mRNA in MDA-MB-231 and MDA-MB-231/GFP cells, but the expression of BMP9 mRNA in MDA-MB-231/BMP9 cells was significant. The proliferation inhibitory rate of MDA-MB-231/BMP9 cells was higher than that of MDA-MB-231/GFP cells (P0.05). The colony-forming rate of MDA-MB-231/BMP9 cells was lower than those of MDA-MB-231/GFP and MDA-MB-231 cells (P0.05). The apoptosis rate of MDA-MB-231/BMP9 cells was higher than those of MDA-MB-231/GFP and MDA-MB-231 cells (P0.05). The xenograft tumor volume in the MDA-MB-231/BMP9 group was smaller than those in the MDA-MB-231/GFP and MDA-MB-231 groups (P0.001). The apoptosis index of xenograft tumor in the MDA-MB-231/BMP9 group was higher than those in the MDA-MB-231/GFP and MDA-MB-231 groups (P0.001). Conclusion: BMP9 can inhibit the proliferation ability and induce the apoptosis of MDA-MB-231 cells in vitro and in vivo.
出处 《肿瘤》 CAS CSCD 北大核心 2011年第5期389-394,共6页 Tumor
基金 国家自然科学基金资助项目(编号:30800658)
关键词 乳腺肿瘤 细胞增殖 细胞凋亡 骨形态发生蛋白9 细胞 MDA-MB-231乳腺肿瘤 细胞增殖 细胞凋亡 骨形态发生蛋白9 细胞 MDA-MB-231 Breast neoplasms Cell proliferation Apoptosis Bone morphogenetic protein 9 Cell MDA-MB-231
  • 相关文献

参考文献22

  • 1DAVID L,MALLET C,KERAMIDAS M,et al.Bone morphogenetic protein-9 is a circulating vascular quiescence factor[J].Circ Res,2008,102(8):914-922.
  • 2YE L,BOKOBZA S M,JIANG W G.Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential[J].Int J Mol Med,2009,24(5):591-597.
  • 3SCHARPFENECKER M,VAN DINTHER M,LIU Z,et al.BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis[J].J Cell Sci,2007,120(Pt6):964-972.
  • 4ALARMOO E L,KORHONEN T,KUUKASJ(A)RVI T,et al.Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas[J].Ann Oncol,2008,19(2):308-314.
  • 5DAVIES S R,WATKINS G,DOUGLAS-JONES A,et al.Bone morphogenetic proteins 1 to 7 in human breast cancer,expression pattern and clinical/prognostic relevance[J].J Exp Ther Oncol,2008,7(4):327-338.
  • 6LANGENFELD E M,CALVANO S E,ABOU-NUKTA F,et al.The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells[J].Carcinogenesis,2003,24(9):1445-1454.
  • 7B0BINAC D,MARI(C) I,ZORICI(C) S,et al.Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer[J].Croat Med J,2005,46(3):389-396.
  • 8ROTHHAMMER T,POSER I,SONCIN F,et al.Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration[J].Cancer Res,2005,65(2):448-456.
  • 9DARBY S,CROSS S S,BROWN N J,et al.BMP-6 over-expression in prostate cancer is associated with increased Id? protein and a more invasive phenotype[J].J pathol,2008,214(3):394-404.
  • 10BUIJS J T,HENRIQUEZ N V,VAN OVERVELD P G,et al.Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer[J].Cancer Res,2007,67(18):8742-8751.

二级参考文献20

  • 1TEITZ T, WEI T, VALENTINE M B, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN[J]. Nat Med, 2000, 6(5) : 529-535.
  • 2AKADA M, CRNOGORAC-JURCEVIC T, LATTIMORE S, et al. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer[ J]. Clin Cancer Res, 2005, 11(8) : 3094-3101.
  • 3WORM J, KIRKIN A F, DZHANDZHUGAZYAN K N ,et al. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells [ J ]. J Biol Chem, 2001,276(43) : 39990-40000.
  • 4HANSEN L T, THYKJAER T, ORNTOFT TF, et al. The role of mismatch repair in small-cell lung cancer cells[ J]. Eur J Cancer, 2003, 39(10) : 1456-1467.
  • 5PLUMB JA, STEELE N, FINN PW, et al. Epigenetic approaches to cancer therapy [ J ]. Biochem Soc Trans, 2004, 32 ( Pt 6 ) : 1095-1097.
  • 6HERMAN J G, GRAFF J R, MYOHANEN S, et al. Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands[ J]. Proc Natl Acad Sci U S A, 1996, 93 ( 18 ) : 9821- 9826.
  • 7YU J, ZHANG H, GU J, et al. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma [ J ]. BMC Cancer, 2004, 465.
  • 8YU J, ZHU T, WANG Z, et al. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer[J]. Clin Cancer Res, 2007, 13(24): 7296-7304.
  • 9ASANO T, NAKAMURA K, FUJII H, et al. Altered expression of topoisomerase Ⅱalpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation [ J ]. Br J Cancer, 2005, 92(8) : 1486-1492.
  • 10DAVID GL,YEGNASUBRAMANIAN S,KUMAR A, et al. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-azacytidine[J]. Cancer Biol Ther, 2004, 3(6) : 540-548.

共引文献4

同被引文献58

  • 1姜晶,王彩芹,刘楠楠.Smad4在乳腺癌及癌周组织中的表达及意义[J].中国老年学杂志,2014,34(5):1253-1255. 被引量:2
  • 2Davies SR, Watkins G, Douglas-Jones A, et al. Bone mor- phogenetic proteins 1 to 7 in human breast cancer, expres- sion pattern and clinical/prognostic relevance [ J ]. J Exp 3"her Oncol, 2008,7 : 327 - 338.
  • 3David L, Mallet C, Keramidas M, et al. Bone morphoge- netic protein-9 is a circulating vascular quiescence factor[J]. Circ Res, 2008, 102:914-922.
  • 4Ye L, Bokobza SM, Jiang WG. Bone morphogenetic pro- teins in development and progression of breast cancer and therapeutic potential[J]. Int J Mol Med, 2009,24:591 - 597.
  • 5Scharpfenecker M, van Dinther M, Liu Z, et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis [ J ]. J Cell Sci, 2007, 120:964 -972.
  • 6Alarmoo EL, Korhonen T, Kuukasjarvi T, et al. Bone mor- phogenetic protein 7 expression associates with bone metas- tasis in breast carcinomas [J]. Ann Oncol, 2008, 19: 308 - 314.
  • 7Herrera B, van Dinther M, Ten Dijke P, et al. Autocrine bone morphogenetie protein-9 signals through activin recep- tor-like kinase-2/Smadl/Smad4 to promote ovarian cancer.cell proliferation [ J ]. Cancer Res, 2009, 24 : 9254 - 9262.
  • 8Ye L, Kynaston H, Jiang WG. Bone morphogenetie pro- tein-9 induces apoptosis in prostate cancer cell, the role of prostate apoptosis response-4 [J]. Mol Cancer Res, 2008, 6 : 1594 - 1606.
  • 9Wang K, Feng HL, Ren W, et al. BMP9 inhibits the pro- liferation and invasiveness of breast cancer cells MDA-MB- 231[J]. J Cancer Res Clin Oncol, 2011, 137:1687 - 1696.
  • 10ALARMO E L, KALLIONIEMI A. Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis? [J]. Endocr Relat cancer, 2010, 17(2):R123-139.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部